Concepedia

Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia

Rossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, Lara Rizzotto, Silvia Martinelli, Gian Matteo Rigolin, Giulia Debbia, Ilaria Castelli, Goretta Bonacorsi, Rita Santachiara,

Experimental Hematology · 2013 · 26 citations · 40 references

DOIFull text

Open access

Concepts

References

40

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

Michael Hallek, Bruce D. Cheson, Daniel Catovsky et al. · Blood · 2008 · 3.2K citations · Full text

, , +14

Thalidomide is an inhibitor of angiogenesis.

Robert J. D’Amato, Michael Loughnan, Evelyn Flynn et al. · Proceedings of the National Academy of Sciences · 1994 · 2.5K citations

, , +14

Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1

Jan A. Burger, Nobuhiro Tsukada, Meike Burger et al. · Blood · 2000 · 734 citations · Full text

, , +11

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

D. Gupta, SP Treon, Yoshihito Shima et al. · Leukemia · 2001 · 555 citations

, , +15

Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study

Asher Chanan‐Khan, Kena C. Miller, Laurie Musial et al. · Journal of Clinical Oncology · 2006 · 409 citations · Full text

, , +14